Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Tau overexpression impacts a neuroinflammation gene expression network perturbed in Alzheimer's disease.

Wes PD, Easton A, Corradi J, Barten DM, Devidze N, DeCarr LB, Truong A, He A, Barrezueta NX, Polson C, Bourin C, Flynn ME, Keenan S, Lidge R, Meredith J, Natale J, Sankaranarayanan S, Cadelina GW, Albright CF, Cacace AM.

PLoS One. 2014 Aug 25;9(8):e106050. doi: 10.1371/journal.pone.0106050. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0121509.

2.

Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027.

Barten DM, Fanara P, Andorfer C, Hoque N, Wong PY, Husted KH, Cadelina GW, Decarr LB, Yang L, Liu V, Fessler C, Protassio J, Riff T, Turner H, Janus CG, Sankaranarayanan S, Polson C, Meredith JE, Gray G, Hanna A, Olson RE, Kim SH, Vite GD, Lee FY, Albright CF.

J Neurosci. 2012 May 23;32(21):7137-45. doi: 10.1523/JNEUROSCI.0188-12.2012.

3.

Tau transgenic mice as models for cerebrospinal fluid tau biomarkers.

Barten DM, Cadelina GW, Hoque N, DeCarr LB, Guss VL, Yang L, Sankaranarayanan S, Wes PD, Flynn ME, Meredith JE, Ahlijanian MK, Albright CF.

J Alzheimers Dis. 2011;24 Suppl 2:127-41. doi: 10.3233/JAD-2011-110161.

PMID:
21422517
4.

A novel long-acting selective neuropeptide Y2 receptor polyethylene glycol-conjugated peptide agonist reduces food intake and body weight and improves glucose metabolism in rodents.

Ortiz AA, Milardo LF, DeCarr LB, Buckholz TM, Mays MR, Claus TH, Livingston JN, Mahle CD, Lumb KJ.

J Pharmacol Exp Ther. 2007 Nov;323(2):692-700. Epub 2007 Aug 1.

5.

Novel selective neuropeptide Y2 receptor PEGylated peptide agonists reduce food intake and body weight in mice.

Lumb KJ, DeCarr LB, Milardo LF, Mays MR, Buckholz TM, Fisk SE, Pellegrino CM, Ortiz AA, Mahle CD.

J Med Chem. 2007 May 3;50(9):2264-8. Epub 2007 Apr 11.

PMID:
17425299
6.

A long-acting selective neuropeptide Y2 receptor PEGylated peptide agonist reduces food intake in mice.

DeCarr LB, Buckholz TM, Milardo LF, Mays MR, Ortiz A, Lumb KJ.

Bioorg Med Chem Lett. 2007 Apr 1;17(7):1916-9. Epub 2007 Jan 24.

PMID:
17292607
7.

Identification of selective neuropeptide Y2 peptide agonists.

DeCarr LB, Buckholz TM, Coish PD, Fathi Z, Fisk SE, Mays MR, O'Connor SJ, Lumb KJ.

Bioorg Med Chem Lett. 2007 Jan 15;17(2):538-41. Epub 2006 Oct 7.

PMID:
17055726
8.

Molecular characterization of a second mouse pancreatic polypeptide receptor and its inactivated human homologue.

Gregor P, Feng Y, DeCarr LB, Cornfield LJ, McCaleb ML.

J Biol Chem. 1996 Nov 1;271(44):27776-81.

9.

Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior.

Hu Y, Bloomquist BT, Cornfield LJ, DeCarr LB, Flores-Riveros JR, Friedman L, Jiang P, Lewis-Higgins L, Sadlowski Y, Schaefer J, Velazquez N, McCaleb ML.

J Biol Chem. 1996 Oct 18;271(42):26315-9.

10.

Cloning and characterization of a novel receptor to pancreatic polypeptide, a member of the neuropeptide Y receptor family.

Gregor P, Millham ML, Feng Y, DeCarr LB, McCaleb ML, Cornfield LJ.

FEBS Lett. 1996 Feb 26;381(1-2):58-62.

11.

Supplemental Content

Loading ...
Support Center